HAV P2C-P3A, Hepatitis A Virus Antigen, Recombinant
| Full Name |
HAV P2C-P3A, Hepatitis A Virus Antigen, Recombinant
|
Abbreviated Name-1 |
Hepatitis P2C-P3A; |
| Documents |
|---|
| Figures |
|---|
| Reference |
|---|
Kusov Y, et al. Silencing of hepatitis A virus infection by small interfering RNAs. J. Virol. Jun 2006; 80(11): 5599-5610.
Nainan OV, et al. Diagnosis of hepatitis a virus infection: a molecular approach. Clin. Microbiol. Rev. Jan 2006; 19(1): 63-79.
Dotzauer A, et al. IgA-coated particles of Hepatitis A virus are translocalized antivectorially from the apical to the basolateral site of polarized epithelial cells via the polymeric immunoglobulin receptor. J. Gen. Virol. Oct 2005; 86(Pt 10): 2747-2751.
|
|
Description |
Hepatitis A Virus (HAV) P2C-P3A is an E. coli-derived recombinant. The protein Hepatitis A Virus (HAV) P2C-P3A contains the P2C-P3A immunodominant region. The protein contains the HAV core proteins P2C-P3A immunodominant regions, amino acids: (1,492-1,606). HAV core proteins are purified by proprietary chromatographic techniques. |
Source |
E. coli |
Purity |
Protein is >90% pure as determined by 10% PAGE (coomassie staining). |
Storage |
Protein is shipped at ambient temperature. Upon arrival, store at -20°C. |
Concentration |
1 mg/ml in 10 mM CBB, pH9.6, 0.1% SDS, glycerol 50%. |
Stability |
Five years frozen. One month in solution at room temperature. |
Specificity |
Immunoreactive with sera of HAV-infected individuals. |
Applications |
Antigen in ELISA and Western blots, excellent antigen for detection of HAV with minimal specificity problems. |
Note |
; |
Related Products
 |
1 |
Custom Recombinant Protein Services: Guaranteed E. coli Expression Package-3 mg purified soluble protein from $2,200 . |
2 |
Bacterial Expression System: GenScript has developed BacPowerTM technologies to tackle hard-to-express and hard-to-dissolve proteins. |
3 |
Yeast Expression System: GenScript's proprietary YeastHIGHTM technology combines the advantages of the bacterial and eukaryotic expression systems. |
4 |
Baculovirus/Insect Cell Expression System: GenScript developed BacuVanceTM platform for the secretion of recombinant proteins from baculovirus-infected insect cells. |
5 |
Mammalian Cell Expression System: The proprietary 293 and CHO suspension system platform promotes fast production and delivery of recombinant proteins and monoclonal antibodies up to grams level. |
|
